Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.

TitleRadiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further Investigation.
Publication TypeJournal Article
Year of Publication2017
AuthorsEscorcia FE, Postow MA, Barker CA
JournalCancer J
Volume23
Issue1
Pagination32-39
Date Published2017 Jan/Feb
ISSN1540-336X
KeywordsAnimals, Combined Modality Therapy, Humans, Immunotherapy, Melanoma, Membrane Glycoproteins, Membrane Transport Proteins, Programmed Cell Death 1 Receptor, Randomized Controlled Trials as Topic, Treatment Outcome
Abstract

Radiotherapy and immune checkpoint blockade are effective treatments for melanoma. Recent preclinical studies have suggested an interaction of radiotherapy and immune checkpoint blockade. Retrospective clinical studies, as well as a small number of prospective studies, have been undertaken to explore this interaction in patients with melanoma. In this review, we present the results of clinical studies combining radiotherapy and immune checkpoint blockade and conclude that this is a promising strategy worth of further investigation.

DOI10.1097/PPO.0000000000000236
Alternate JournalCancer J
PubMed ID28114252
PubMed Central IDPMC5300083
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States

Person Type: